Skip to main content
letter
. 2018 Nov 20;131(22):2765–2766. doi: 10.4103/0366-6999.245268

Table 1.

Percentages of T-cell subsets of healthy controls versus patient (%)

T-cell subsets Controls* versus patient

Severe lymphopenia Lymphocyte reversal


Blood BALF Blood BALF
IFN-γ
 CD4+ 13.23 ± 1.49 versus 1.03 15.47 ± 4.72 versus 1.69 13.23 ± 1.49 versus 16.9 15.47 ± 4.72 versus 21.2
 CD8+ 23.43 ± 3.79 versus 0.82 33.33 ± 6.20 versus 1.06 23.43 ± 3.79 versus 30.3 33.33 ± 6.20 versus 36.1
IL-4
 CD4+ 0.35 ± 0.07 versus 0.14 1.613 ± 0.54 versus 0.26 0.35 ± 0.07 versus 0.52 1.61 ± 0.54 versus 1.84
 CD8+ 0.71 ± 0.24 versus 0.21 1.66 ± 0.724 versus 0.18 0.71 ± 0.24 versus 0.71 1.66 ± 0.72 versus 1.58
IL-9
 CD4+ 0.87 ± 0.28 versus 0.48 3.82 ± 0.77 versus 1.98 0.87 ± 0.28 versus 1.46 3.82 ± 0.77 versus 11.6
 CD8+ 1.03 ± 0.13 versus 0.34 4.45 ± 0.74 versus 0.82 1.03 ± 0.13 versus 1.34 4.45 ± 0.74 versus 11.1
IL-17
 CD4+ 1.12 ± 0.36 versus 0.32 1.96 ± 1.00 versus 0.51 1.12 ± 0.36 versus 1.10 1.96 ± 1.00 versus 3.11
 CD8+ 0.75 ± 0.18 versus 0.14 1.59 ± 0.76 versus 0.19 0.75 ± 0.18 versus 1.56 1.59 ± 0.76 versus 2.55
PD-1
 CD4+ 14.6 ± 1.12 versus 40.2 17.4 ± 1.19 versus 45.5 14.6 ± 1.12 versus 23.1 17.4 ± 1.19 versus 31.1
 CD8+ 13.8 ± 3.29 versus 30.0 17.6 ± 2.25 versus 35.6 13.8 ± 3.29 versus 17.3 17.6 ± 2.25 versus 25.4
Treg 7.10 ± 0.48 versus 1.11 10.4 ± 3.16 versus 2.54 7.10 ± 0.48 versus 10.3 10.4 ± 3.16 versus 11.2

*Data of the healthy donors (n = 3) are presented as mean ± SD. BALF: Bronchoalveolar lavage fluid; IFN-γ: Interferon-γ; IL-4: Interleukin-4; IL-9: Interleukin-9; IL-17: Interleukin-17; PD-1: Programmed cell death-1; Treg: Regulatory T-cell; SD: Standard deviation.